Connection
Sharon Grady to Radioligand Assay
This is a "connection" page, showing publications Sharon Grady has written about Radioligand Assay.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.065 |
|
|
|
-
Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P. a6ß2*-subtype nicotinic acetylcholine receptors are more sensitive than a4ß2*-subtype receptors to regulation by chronic nicotine administration. J Neurochem. 2014 Jul; 130(2):185-98.
Score: 0.027
-
O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, McIntosh JM, Lindstrom JM, Lester HA, Grady SR, Marks MJ. Mice expressing the ADNFLE valine 287 leucine mutation of the ?2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function. Pharmacol Biochem Behav. 2013 Jan; 103(3):603-21.
Score: 0.024
-
Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology. 2005 Apr; 48(5):696-705.
Score: 0.014